Ray F. Ebert

2.2k total citations
29 papers, 571 citations indexed

About

Ray F. Ebert is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ray F. Ebert has authored 29 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ray F. Ebert's work include Mesenchymal stem cell research (5 papers), Tissue Engineering and Regenerative Medicine (5 papers) and Blood properties and coagulation (4 papers). Ray F. Ebert is often cited by papers focused on Mesenchymal stem cell research (5 papers), Tissue Engineering and Regenerative Medicine (5 papers) and Blood properties and coagulation (4 papers). Ray F. Ebert collaborates with scholars based in United States, Germany and Netherlands. Ray F. Ebert's co-authors include Jozef Kaiser, Masahiko Sato, Thomas D. Pollard, Karen I. Miller, Psyche Lee, Lem Moyé, Robert D. Simari, Emerson C. Perin, Kunio Tsurugi and Joshua M. Hare and has published in prestigious journals such as Circulation, The Journal of Cell Biology and Gastroenterology.

In The Last Decade

Ray F. Ebert

28 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ray F. Ebert United States	14	206	168	112	96	65	29	571
Pertteli Salmenperä Finland	17	250 1.2×	86 0.5×	91 0.8×	38 0.4×	22 0.3×	25	758
Ahmad Hosseini Iran	17	275 1.3×	111 0.7×	262 2.3×	118 1.2×	34 0.5×	84	875
T M Chiang United States	15	215 1.0×	67 0.4×	62 0.6×	50 0.5×	18 0.3×	35	716
Mahtab Nourbakhsh Germany	18	400 1.9×	80 0.5×	288 2.6×	46 0.5×	26 0.4×	46	887
Sayaka Kawano Japan	11	254 1.2×	64 0.4×	122 1.1×	33 0.3×	11 0.2×	36	565
Elżbieta Karnas Poland	16	394 1.9×	73 0.4×	70 0.6×	82 0.9×	62 1.0×	40	692
Andrei Constantinescu France	14	411 2.0×	74 0.4×	477 4.3×	43 0.4×	55 0.8×	25	929
Danielle Smith United States	16	771 3.7×	68 0.4×	55 0.5×	39 0.4×	17 0.3×	37	1.1k

Countries citing papers authored by Ray F. Ebert

Since Specialization

Citations

This map shows the geographic impact of Ray F. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray F. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray F. Ebert more than expected).

Fields of papers citing papers by Ray F. Ebert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ray F. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray F. Ebert. The network helps show where Ray F. Ebert may publish in the future.

Co-authorship network of co-authors of Ray F. Ebert

This figure shows the co-authorship network connecting the top 25 collaborators of Ray F. Ebert. A scholar is included among the top collaborators of Ray F. Ebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ray F. Ebert. Ray F. Ebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taylor, Doris A., Luiz C. Sampaio, Emerson C. Perin, et al.. (2021). Recommendations for nomenclature and definition of cell products intended for human cardiovascular use. Cardiovascular Research. 118(11). 2428–2436. 7 indexed citations

Bolli, Roberto, Joshua M. Hare, Timothy D. Henry, et al.. (2018). Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial. American Heart Journal. 201. 54–62. 19 indexed citations

Ebert, Ray F., Narasimhan Danthi, Marc Charette, et al.. (2016). The NHLBI SMARTT Program. Circulation Research. 118(12). 1867–1871. 1 indexed citations

Ambale‐Venkatesh, Bharath, Victor Nauffal, Phillip C. Yang, et al.. (2016). Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network “Patients with Intermittent Claudication Injected with ALDH Bright Cells” (CCTRN PACE) study. American Heart Journal. 183. 24–34. 10 indexed citations

Golpanian, Samuel, Ivonne Hernandez Schulman, Ray F. Ebert, et al.. (2015). Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease. Stem Cells Translational Medicine. 5(2). 186–191. 94 indexed citations

Perin, Emerson C., Michael P. Murphy, John P. Cooke, et al.. (2014). Rationale and Design for PACE: Patients with Intermittent Claudication Injected with ALDH Bright Cells. American Heart Journal. 168(5). 667–673.e2. 19 indexed citations

Simari, Robert D., Carl J. Pepine, Jay H. Traverse, et al.. (2014). Bone Marrow Mononuclear Cell Therapy for Acute Myocardial Infarction. Circulation Research. 114(10). 1564–1568. 28 indexed citations

Holtkamp, W., et al.. (2008). Ultraschallgesteuerte Feinnadelpunktion: Grenzen der Methode im Abdomen und Retroperitonealraum. DMW - Deutsche Medizinische Wochenschrift. 115(21). 809–812.

Ng, Valerie L., et al.. (1998). Highly Sensitive Thromboplastins Do Not Improve INR Precision. American Journal of Clinical Pathology. 109(3). 338–346. 7 indexed citations

10.

Ebert, Ray F., et al.. (1996). Keyhole limpet hemocyanin: Structural and functional characterization of two different subunits and multimers. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 113(3). 537–548. 67 indexed citations

11.

Ratliff, Timothy L., et al.. (1994). Immunotherapy with Keyhole Limpet Hemocyanin: Efficacy and Safety in the MB-49 Intravesical Murine Bladder Tumor Model. The Journal of Urology. 151(6). 1718–1722. 20 indexed citations

12.

Ebert, Ray F., et al.. (1994). Species specificity of ELISAs for prothrombin fragment F1.2. Thrombosis Research. 75(6). 657–662. 1 indexed citations

13.

Eaton, Amanda, et al.. (1993). A comparative evaluation of ELISAs for D-dimer and related fibrin(ogen) degradation products. Blood Coagulation & Fibrinolysis. 4(4). 537–550. 30 indexed citations

14.

Ebert, Ray F., et al.. (1990). Immunotoxin construction with a ribosome-inactivating protein from barley. Bioconjugate Chemistry. 1(5). 331–336. 14 indexed citations

15.

Schmelzer, Charles H., Ray F. Ebert, & William R. Bell. (1989). Fibrinogen baltimore iv: congenital dysfibrinogenemia with a γ275 (ARG → CYS) substitution. Thrombosis Research. 56(2). 307–316. 13 indexed citations

16.

Ebert, Ray F. & Charles H. Schmelzer. (1988). Isolation and comparative peptide mapping of fibrinogen subunits by reversed-phase high-performance liquid chromatography. Journal of Chromatography A. 443. 309–316. 10 indexed citations

17.

Endo, Yaeta, Kunio Tsurugi, & Ray F. Ebert. (1988). The mechanism of action of barley toxin: a type 1 ribosome-inactivating protein with RNA N-glycosidase activity. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 954(2). 224–226. 33 indexed citations

18.

Kaiser, Jozef, Masahiko Sato, Ray F. Ebert, & Thomas D. Pollard. (1986). Purification and characterization of two isoforms of Acanthamoeba profilin.. The Journal of Cell Biology. 102(1). 221–226. 68 indexed citations

19.

Ebert, Ray F. & William R. Bell. (1985). Fibrinogen baltimore IV: Congenital dysfibrinogenemia with delayed fibrin monomer polymerization. Thrombosis Research. 38(2). 121–128. 9 indexed citations

20.

Lembcke, B., Ray F. Ebert, M. Ptok, et al.. (1984). Role of gastrointestinal transit in the delay of absorption by viscous fibre (guar).. PubMed. 31(4). 183–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact